ArticleCancers2021

ADCC against MICA/B Is Mediated against Differentiated Oral and Pancreatic and Not Stem-Like/Poorly Differentiated Tumors by the NK Cells; Loss in Cancer Patients due to Down-Modulation of CD16 Receptor.

Kawaljit Kaur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.